Coppertone, One-A-Day Sales Slump As Bayer’s Consumer Health Slide Continues
This article is powered by The Rose Sheet
Executive Summary
Bayer reported consumer health sales globally fell 1.4% to $1.64bn after a late start to the allergy season drove down Claritin sales. Aleve analgesics sales grew 3.3% to $112.5m on US line extensions while Alka Seltzer line sales were flat at $47.5m.
You may also be interested in...
Bayer Suggests Self-Care Industry Follow Five Principles As 'Blueprint' For Product Development
Bayer proposes five science-based principles to guide industry’s self-care research and development to reframe self-care and earn consumer trust.
Bayer And Consumer Health, Like Hand In Glove
“This is an amazing time to be in consumer health. Why would you get rid of an amazing business?” says Heiko Schipper, Bayer's consumer health chief since 2018.
J&J Rides Standalone Consumer Health Track
J&J takes same approach GSK, Pfizer, Merck & Co, Merck and Novartis have with their consumer health businesses, Bausch Health is starting and Sanofi says it will.